TCT

This channel contains news about the annual Transcatheter Cardiovascular Therapeutics (TCT) conference presented by the Cardiovascular Research Foundation (CRF). It includes coverage from the annual meeting and links CRF news. TCT is the premier conference for the subspecialty of interventional cardiology, including the new subspecialty areas of transcatheter structural heart procedures. 

The Impella CP with SmartAssist heart pump is a minimally invasive, temporary heart pump that uses real-time intelligence associated with improved survival and heart recovery. (Graphic: Business Wire)
Feature | Cardiovascular Business | By Melinda Taschetta-Millane
Top 10: Most-read Content in September

Here is a recap of what DAIC viewers found most interesting during the month of September:


1. Unloading with Impella ...

Home October 03, 2022
Home
The Transcatheter Cardiovascular Therapeutics (TCT) conference, which is the Cardiovascular Research Foundation's (CRF) annual scientific symposium and one of the world's foremost educational forum specializing in interventional cardiovascular medicine, is marking its 34th year in 2022, from September 16-19 in Boston, returning to its pre-pandemic format.
Gallery | TCT | By Melinda Taschetta-Millane and Christine Book
Photo Gallery Highlighting TCT 2022

The Photo Gallery includes images taken by DAIC's editorial team at the 34th Transcatheter Cardiovascular Therapeutics ( ...

Home October 03, 2022
Home
The multi-center first-in-men study evaluates the safety and performance of the next generation of BIOTRONIK’s Resorbable Magnesium Scaffold (RMS)
News | Stents Bioresorbable
BIOMAG-I Clinical Trial Reaches Primary Endpoint at Six Month for Unique Next Generation Resorbable Magnesium Scaffold

September 28, 2022 —  In the "TCT Innovation" session Prof. Michael Haude, BIOMAG-I Coordinating Clinical Investigator ...

Home September 28, 2022
Home
Magmaris Scaffold Performs Well in Real World Settings Even in More Complex Patient Groups
News | Stents Bioresorbable
BIOSOLVE-IV Full-Cohort Two-Year Data Confirm Excellent Safety and Efficacy Profile of Magmaris Resorbable Magnesium Scaffold

September 27, 2022 —  BIOTRONIK announced the presentation of new full-cohort 2-year BIOSOLVE-IV data. In a poster ...

Home September 27, 2022
Home
Edwards Lifesciences announced the launch of the SAPIEN 3 Ultra RESILIA valve, which incorporates Edwards' breakthrough RESILIA tissue technology with the industry-leading SAPIEN 3 Ultra transcatheter aortic heart valve.
News | Heart Valve Technology
Edwards Launches Sapien 3 Ultra Resilia Valve Following FDA Approval

September 26, 2022 — Edwards Lifesciences announced the launch of the SAPIEN 3 Ultra RESILIA valve, which incorporates ...

Home September 26, 2022
Home
Study of the Paradise Ultrasound Renal Denervation System Shows Significant Reduction in Blood Pressure in Patients with Uncontrolled Hypertension
News | Hypertension
ReCor Medical Announces Results of RADIANCE II Pivotal Trial at TCT 2022 Annual Meeting

September 26, 2022 — ReCor Medical, Inc., a wholly owned subsidiary of Otsuka Medical Devices Co., Ltd., announced the ...

Home September 26, 2022
Home
Abiomed (ABMD) announces the result of a three-year, investigator-led study of all Impella-supported patients treated at 109 hospitals in Japan shows a 30-day survival rate of 77% for patients with cardiogenic shock due to myocarditis.
News | Cardiogenic Shock
Multi-Center, Multi-Society Study of Impella-supported Patients with Cardiogenic Shock due to Myocarditis in Japan Achieves 30-day Survival of 77%

September 22, 2022 — Abiomed (ABMD) announces the result of a three-year, investigator-led study of all Impella ...

Home September 22, 2022
Home
David J. Cohen, MD, MSc, St. Francis Hospital and CRF, presented Jennifer A. Rymer, MD, Duke University Medical Center with the TCT 2022 Thomas J. Linnemeier Young Investigator Award, along with co-presenter Gary S. Mintz of the Cardiovascular Research Foundation (CRF) on Sept 19 in Boston, MA.
News | TCT
TCT 2022 Honors Recipient of Thomas J. Linnemeier Young Investigator Award

September 22, 2022 — The recipient of the TCT 2022 Thomas J. Linnemeier “Spirit of Interventional Cardiology” Young ...

Home September 22, 2022
Home
Statistically significant mean reductions of 10.3 mmHg in 24-hour ambulatory systolic blood pressure and 11.7 mmHg in ambulatory pulse pressure after 6 months of therapy in control patients who crossed over to BackBeat CNT following completion of the randomized portion of the MODERATO II study
News | Hypertension
Orchestra BioMed Announces Presentation of Positive Long-Term Clinical Results from MODERATO II Control Patients Crossover Extension Study of BackBeat CNT at TCT 2022

September 20, 2022 — Orchestra BioMed, Inc., a biomedical innovation company accelerating high-impact technologies to ...

Home September 20, 2022
Home
Results of the CLASP IID Trial Presented at TCT and published simultaneously in JACC: Cardiovascular Interventions
News | Structural Heart
Novel TEER Repair Device Meets Primary Endpoint in Treating Degenerative Mitral Regurgitation in Patients Not Eligible for Surgery

September 20, 2022 — Results of the first randomized controlled trial to directly compare two contemporary transcatheter ...

Home September 20, 2022
Home
Results from TVT registry analysis presented at TCT and published simultaneously in the Journal of the American College of Cardiology
News | Cardiogenic Shock
STS/ACC TVT Registry Analysis Assesses Use of Transcatheter Edge-to-Edge Repair in Severe Mitral Regurgitation and Cardiogenic Shock

September 20, 2022 —  An analysis from the Society of Thoracic Surgeons/American College of Cardiology(STS/ACC) TVT ...

Home September 20, 2022
Home
The TCT 2022 Innovation Shark Tank Competition award presentation was held Sept. 19, in Boston, MA. Shown here announcing the winner, Puzzle Medical Devices, are Robert Schwartz, MD, and Juan F. Granada, President and CEO of the Cardiovascular Research Foundation (CRF).
News | TCT
TCT 2022 Announces Winner of Shark Tank Innovation Award

September 19, 2022 — Puzzle Medical Devices, a provider of hemodynamic support in Heart Failure (HF), was selected as ...

Home September 20, 2022
Home
FIH study demonstrated feasibility and safety of cardiorenal support among patients undergoing high-risk PCI
News | Heart Failure
First-in-Human Study Finds Mechanical Circulatory Support and Renal Perfusion Success with the ModulHeart Device

September 19, 2022 —  A first-in-human (FIH) study using the ModulHeart device (Puzzle Medical Devices Inc.) has ...

Home September 19, 2022
Home
Results also demonstrate the benefits for patients of Abbott's TriClip™ for tricuspid regurgitation, Amulet™ for atrial fibrillation and Portico™ for aortic stenosis
News | Structural Heart
Late-Breaking Data Show Breadth of Abbott's Minimally Invasive Structural Heart Technologies

September 17, 2022 — Abbott today announced data from five late-breaking presentations showing the benefits of its ...

Home September 17, 2022
Home
Pathological Findings Confirm Importance of Early Detection and Treatment of Thrombus on Valve Leaflets
News | Structural Heart
First-ever Comparison of MicroCT and Histology in Self-expanding Transcatheter Aortic Valve Replacement Patients with Hypo-attenuated Leaflet Thickening

September 17, 2022 — Medtronic today announced findings from its Pathological Study of Hypo-Attenuated Leaflet ...

Home September 17, 2022
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now